Relationship of sex hormones and nocturia in lower urinary tract symptoms induced by benign prostatic hyperplasia

Aging Male

Volumn 15, Issue 2, 2012, Pages 90-95

  Kim, Myung Ki ^a,b   Zhao, Chen ^a,b   Kim, Sang Deuk ^a,b   Kim, Dong Gon ^a,b   Park, Jong Kwan ^a,b  

^a Chonbuk National University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

Benign prostatic hyperplasia; Lower urinary tract symptoms; Nocturia; Sex hormones

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ESTRADIOL; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TESTOSTERONE BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY; URINE; URINE FLOW RATE;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; ESTRADIOL; HUMANS; MALE; NOCTURIA; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; TESTOSTERONE;

EID: 84860843752     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2012.659715     Document Type: Article

References (35)

1. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993;150:85-89.
2. Liu CC, Wang CJ, Huang SP, Chou YH, Wu WJ, Huang CH. Relationships between American Urological Association symptom index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia. Kaohsiung J Med Sci 2004;20:273-278.
3. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-479.
4. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 1991;145:405-409.
5. Montie JE, Pienta KJ. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. Urology 1994;43:892-899.
6. Griffiths K, Eaton CL, Harper ME, Peeling B, Davies P. Steroid hormones and the pathogenesis of benign prostatic hyperplasia. Eur Urol 1991;20 Suppl 1:68-77.
7. Bruchovsky N, Rennie PS, Batzold FH, Goldenberg SL, Fletcher T, McLoughlin MG. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J Clin Endocrinol Metab 1988;67:806-816.
8. Barrack ER, Bujnovszky P, Walsh PC. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors. Cancer Res 1983;43:1107-1116.
9. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993;150:351-358.
10. Amano T, Imao T, Takemae K, Iwamoto T, Nakanome M. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients. Aging Male 2010;13:242-246.
11. Wu JL, Wu RS, Yang JG, Huang CC, Chen KB, Fang KH, Tsai HD. Effects of sleep deprivation on serum testosterone concentrations in the rat. Neurosci Lett 2011;494:124-129.
12. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4; discussion 74.
13. Presti JC Jr, O'Dowd GJ, Miller MC, Mattu R, Veltri RW. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003;169:125-129.
14. Choi KS, Park JK. Epidemiologic characteristics of prostate cancerdetection. Korean J Urol 2009;50:1054-1058.
15. Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, Reding D, et al. Risk behaviours and benign prostatic hyperplasia. BJU Int 2004;93:1241-1245.
16. Jin B, Turner L, Zhou Z, Zhou EL, Handelsman DJ. Ethnicity and migration as determinants of human prostate size. J Clin Endocrinol Metab 1999;84:3613-3619.
17. Li MK, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int 2005;96:1339-1354.
18. Platz EA, Smit E, Curhan GC, Nyberg LM, Giovannucci E. Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology 2002;59:877-883.
19. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:469-471.
20. Schatzl G, Brössner C, Schmid S, Kugler W, Roehrich M, Treu T, Szalay A, et al. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology. Urology 2000;55:397-402.
21. Madersbacher S, Haidinger G, Temml C, Schmidbauer CP. Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2,096 men. Eur Urol 1998;34:136-141.
22. Sciarra F, Toscano V. Role of estrogens in human benign prostatic hyperplasia. Arch Androl 2000;44:213-220.
23. Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol 2004;172:1399-1403.
24. Andersen ML, Tufik S. The effects of testosterone on sleep and sleepdisordered breathing in men: its bidirectional interaction with erectile function. Sleep Med Rev 2008;12:365-379.
25. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA 2011;305:2173-2174.
26. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 1998;338:557-563.
27. Yeh S, Miyamoto H, Shima H, Chang C. From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci USA 1998;95:5527-5532.
28. Liu CC, Huang SP, Li WM, Wang CJ, Chou YH, Li CC, Huang CH, Wu WJ. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Urology 2007;70:677-680.
29. Joseph MA, Wei JT, Harlow SD, Cooney KA, Dunn RL, Jaffe CA, Montie JE, Schottenfeld D. Relationship of serum sex-steroid hormones and prostate volume in African American men. Prostate 2002;53:322-329.
30. Meikle AW, Stephenson RA, Lewis CM, Middleton RG. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins. J Clin Endocrinol Metab 1997;82:571-575.
31. Roberts RO, Jacobson DJ, Rhodes T, Klee GG, Leiber MM, Jacobsen SJ. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 2004;61:124-131.
32. Rohrmann S, Nelson WG, Rifai N, Kanarek N, Basaria S, Tsilidis KK, Smit E, et al. Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III). Urology 2007;69:708-713.
33. Tsurusaki T, Aoki D, Kanetake H, Inoue S, Muramatsu M, Hishikawa Y, Koji T. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia. J Clin Endocrinol Metab 2003;88:1333-1340.
34. Koritsiadis G, Stravodimos K, Mitropoulos D, Doumanis G, Fokitis I, Koritsiadis S, Constantinides C. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study. BJU Int 2008;101:1542-1546.
35. Schultheiss D, Machtens S, Jonas U. Testosterone therapy in the ageing male: what about the prostate? Andrologia 2004;36: 355-365.